Arcadia Biosciences (RKDA) Retained Earnings (2014 - 2025)

Arcadia Biosciences has reported Retained Earnings for 12 years, with the latest figure at -$281.2 million in Q4 2025.

• For the quarter ending Q4 2025, Retained Earnings fell 0.84% year-over-year to -$281.2 million; the trailing twelve-month figure through Dec 2025 stood at -$281.2 million (down 0.84% YoY), and the FY2025 full-year result was -$281.2 million, down 0.84% from the prior year.
• Retained Earnings for Q4 2025 stood at -$281.2 million, roughly flat from -$279.9 million in the prior quarter.
• The five-year high for Retained Earnings was $161000.0 in Q1 2024, with the low at -$281.2 million in Q4 2025.
• Historically, Retained Earnings has averaged -$234.1 million across 5 years, with a median of -$266.8 million in 2023.
• Annual changes were most pronounced in 2022 — Retained Earnings plunged 2089066.67% — and 2024, when it soared 100.06%.
• Arcadia Biosciences' Retained Earnings stood at -$226.5 million in 2021, then retreated by 13.85% to -$257.9 million in 2022, then fell by 5.42% to -$271.8 million in 2023, then slipped by 2.59% to -$278.9 million in 2024, then fell by 0.84% to -$281.2 million in 2025.
• The last three Retained Earnings figures came in at -$281.2 million (Q4 2025), -$279.9 million (Q3 2025), and -$280.7 million (Q2 2025), per Business Quant data.